Astellas Adds Second Drug to 340B Contract Pharmacy Restrictions
Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...]
*Sign up for news summaries and alerts from 340B Report